When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOV - Why Myovant Sciences Stock Is Up Triple Digits Today
Myovant Sciences Ltd.
Shares of Myovant Sciences(NYSE: MYOV) are skyrocketing today, up 161% as of 10:45 a.m. EST, after the clinical-stage biotech released results from its phase 3 HERO study.
The HERO study was designed to test the safety and efficacy of Myovant's lead compound, relugolix, as a hopeful treatment for men with androgen-sensitive advanced prostate cancer who required at least one year of continuous androgen deprivation therapy. The trial pitted relugolix against the current standard-of-care treatment leuprolide acetate.